ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 569,89
-0,82%
Dow Jones
40 211,72
0,53%
DAX
18 468,03
-0,71%
Brent Oil
83,60
-0,88%
Bitcoin
62 666,33
-3,37%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
30/07/201908h02UK RegulatoryHutchison China Meditech Limited 2019 Interim Results and Clinical Programs UpdateLSE:0J7GHutchison China Meditech Ltd
10/07/201917h35UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
03/07/201909h02UK RegulatoryHutchison China Meditech Limited TR-1: Form for notification of major holdingsLSE:0J7GHutchison China Meditech Ltd
03/07/201908h00UK RegulatoryHutchison China Meditech Limited Chi-Med to Announce 2019 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
28/06/201912h10UK RegulatoryHutchison China Meditech Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
28/06/201911h07UK RegulatoryHutchison China Meditech Limited Pricing of U.S. Public Secondary Offering of ADSsLSE:0J7GHutchison China Meditech Ltd
28/06/201908h01UK RegulatoryHutchison China Meditech Limited Secondary Offering of American Depositary SharesLSE:0J7GHutchison China Meditech Ltd
21/06/201917h40UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
14/06/201910h00UK RegulatoryHutchison China Meditech Limited Surufatinib Phase III Study Meets Primary EndpointLSE:0J7GHutchison China Meditech Ltd
12/06/201910h18UK RegulatoryHutchison China Meditech Limited Block Admission Applications & Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
06/06/201908h01UK RegulatoryHutchison China Meditech Limited Disclosure UpdateLSE:0J7GHutchison China Meditech Ltd
29/05/201913h06UK RegulatoryHutchison China Meditech Limited Results of Extraordinary General MeetingLSE:0J7GHutchison China Meditech Ltd
22/05/201912h03UK RegulatoryHutchison China Meditech Limited Grant of Share Options under Share Option SchemeLSE:0J7GHutchison China Meditech Ltd
29/03/201908h02RNS Non-RegulatoryHutchison China Meditech Limited Start of Phase IIb/III Surufatinib Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
28/03/201908h30RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib Lung Cancer Presentations at AACRLSE:0J7GHutchison China Meditech Ltd
11/03/201913h54RNS Non-RegulatoryHutchison China Meditech Limited Publication of Form 20-FLSE:0J7GHutchison China Meditech Ltd
12/02/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib PRCC Data to be presented at ASCO GULSE:0J7GHutchison China Meditech Ltd
07/01/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Presents at JPM Healthcare ConferenceLSE:0J7GHutchison China Meditech Ltd
29/11/201809h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Enters into Multiple CollaborationsLSE:0J7GHutchison China Meditech Ltd
26/11/201808h01RNS Non-RegulatoryHutchison China Meditech Limited First Commercial Launch of Fruquintinib CapsulesLSE:0J7GHutchison China Meditech Ltd
18/10/201808h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Initiates a Ph I Trial of HMPL-523 for AMLLSE:0J7GHutchison China Meditech Ltd
27/07/201808h00UK RegulatoryHutchison China Meditech Limited 2018 Interim Results and Clinical Programs UpdateLSE:0J7GHutchison China Meditech Ltd
23/07/201808h00RNS Non-RegulatoryHutchison China Meditech Limited Start of Sulfatinib US Phase Ib/II PoC trialLSE:0J7GHutchison China Meditech Ltd
29/06/201808h02UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
29/06/201808h01UK RegulatoryHutchison China Meditech Limited Chi-Med to Announce Half-Year Financial ResultsLSE:0J7GHutchison China Meditech Ltd
04/06/201810h41RNS Non-RegulatoryHutchison China Meditech Limited Further Fruquintinib FRESCO Trial Data - ASCO 2018LSE:0J7GHutchison China Meditech Ltd
27/04/201814h52UK RegulatoryHutchison China Meditech Limited Results of Annual General MeetingLSE:0J7GHutchison China Meditech Ltd
23/04/201814h05UK RegulatoryHutchison China Meditech Limited Block AdmissionLSE:0J7GHutchison China Meditech Ltd
28/03/201808h01UK RegulatoryHutchison China Meditech Limited Vesting of awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
26/03/201808h00UK RegulatoryHutchison China Meditech Limited Annual Report & Notice of Annual General MeetingLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
EU
CAP
Capgemini
USI
USTECH100
US Tech 100
EU
VIV
Vivendi
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
EU
LR
Legrand
FTSE
UKX
FTSE 100
EU
RI
Pernod Ricard
EU
PX1
CAC 40
EU
BN
Danone
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés